$LMMY
LAMY

2024 Q2 Form 10-K Financial Statement

#000168316824006126 Filed on August 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 2023 Q2
Revenue $11.50K
YoY Change
Cost Of Revenue $9.667K
YoY Change
Gross Profit $1.833K
YoY Change
Gross Profit Margin 15.94%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.033K
YoY Change 0.0%
% of Gross Profit 274.58%
Operating Expenses $28.08K
YoY Change -50.24%
Operating Profit -$26.24K
YoY Change -53.49%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $436.00
YoY Change
Pretax Income -$25.81K
YoY Change -54.26%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$25.81K
YoY Change -54.26%
Net Earnings / Revenue -224.41%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 7.777M shares 7.777M shares 7.777M shares
Diluted Shares Outstanding 7.777M shares

Balance Sheet

Concept 2024 Q2 2024 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.028K $7.855K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $11.50K $0.00
Other Receivables
Total Short-Term Assets $12.96K $7.855K
YoY Change 65.04% -22.28%
LONG-TERM ASSETS
Property, Plant & Equipment $4.952K $9.986K
YoY Change -50.41% -33.51%
Goodwill
YoY Change
Intangibles $9.537K $19.20K
YoY Change -50.34% -33.48%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $14.49K $29.19K
YoY Change -50.36% -33.49%
TOTAL ASSETS
Total Short-Term Assets $12.96K $7.855K
Total Long-Term Assets $14.49K $29.19K
Total Assets $27.45K $37.04K
YoY Change -25.89% -31.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.211K $610.00
YoY Change 98.52%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.17K $3.610K
YoY Change 292.49%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $68.18K $62.52K
YoY Change 9.05% 14.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.17K $3.610K
Total Long-Term Liabilities $68.18K $62.52K
Total Liabilities $82.35K $66.13K
YoY Change 24.52% 21.49%
SHAREHOLDERS EQUITY
Retained Earnings -$83.17K -$57.36K
YoY Change 44.99% 6021.45%
Common Stock $778.00 $778.00
YoY Change 0.0% 55.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$54.90K -$29.09K
YoY Change
Total Liabilities & Shareholders Equity $27.45K $37.04K
YoY Change -25.89% -31.39%

Cashflow Statement

Concept 2024 Q2 2024 2023 Q2
OPERATING ACTIVITIES
Net Income -$25.81K
YoY Change -54.26%
Depreciation, Depletion And Amortization $5.033K
YoY Change 0.0%
Cash From Operating Activities -$12.48K
YoY Change -67.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.657K
YoY Change -84.22%
NET CHANGE
Cash From Operating Activities -$12.48K
Cash From Investing Activities $0.00
Cash From Financing Activities $5.657K
Net Change In Cash -$6.827K
YoY Change 203.15%
FREE CASH FLOW
Cash From Operating Activities -$12.48K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56421 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7855 usd
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001939937
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
000-56599
CY2024 dei Entity Registrant Name
EntityRegistrantName
LAMY
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-2039216
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Allen Street
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 10104
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
New York City
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10002
CY2024 dei City Area Code
CityAreaCode
657
CY2024 dei Local Phone Number
LocalPhoneNumber
315-8312
CY2024 dei Security12b Title
Security12bTitle
Common Stock
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7777000 shares
CY2023Q4 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024 dei Auditor Name
AuditorName
BOLADALE LAWAL & CO.
CY2024 dei Auditor Firm
AuditorFirmId
6993
CY2024 dei Auditor Location
AuditorLocation
Lagos, Nigeria
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7855 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11500 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
436 usd
CY2023Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
12964 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
7855 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9537 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19203 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4952 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9986 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
14489 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
29189 usd
CY2024Q2 us-gaap Assets
Assets
27453 usd
CY2023Q2 us-gaap Assets
Assets
37044 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1211 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
610 usd
CY2024Q2 LAMY Advances From Related Parties
AdvancesFromRelatedParties
12958 usd
CY2023Q2 LAMY Advances From Related Parties
AdvancesFromRelatedParties
3000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14169 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3610 usd
CY2024Q2 LAMY Loans From Related Parties
LoansFromRelatedParties
18100 usd
CY2023Q2 LAMY Loans From Related Parties
LoansFromRelatedParties
18100 usd
CY2024Q2 LAMY Note Payable Related Party
NotePayableRelatedParty
10000 usd
CY2023Q2 LAMY Note Payable Related Party
NotePayableRelatedParty
10000 usd
CY2024Q2 us-gaap Other Notes Payable
OtherNotesPayable
29000 usd
CY2023Q2 us-gaap Other Notes Payable
OtherNotesPayable
29000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11079 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5422 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
68179 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
62522 usd
CY2024Q2 us-gaap Liabilities
Liabilities
82348 usd
CY2023Q2 us-gaap Liabilities
Liabilities
66132 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
778 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
778 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27492 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27492 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83165 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57358 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-54895 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-29088 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27453 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37044 usd
CY2024 us-gaap Revenues
Revenues
11500 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
9667 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024 us-gaap Gross Profit
GrossProfit
1833 usd
CY2023 us-gaap Gross Profit
GrossProfit
0 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28076 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56421 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
28076 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
56421 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
436 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25807 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-25807 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-56421 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7777000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7777000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5686257 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5686257 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-29088 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-25807 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-54895 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-437 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25270 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2500 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-56421 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-29088 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-25807 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-56421 usd
CY2024 us-gaap Depreciation
Depreciation
5033 usd
CY2023 us-gaap Depreciation
Depreciation
5033 usd
CY2024 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9667 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9667 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11500 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
CY2024 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
436 usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-0 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
601 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
610 usd
CY2024 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
9958 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
3000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12484 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38111 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27770 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3000 usd
CY2024 LAMY Proceeds From Accrued Interest
ProceedsFromAccruedInterest
5657 usd
CY2023 LAMY Proceeds From Accrued Interest
ProceedsFromAccruedInterest
5089 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5657 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35859 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6827 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2252 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7855 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10107 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024 LAMY Proceeds Of Loan From Related Party In Exchange Of Asset
ProceedsOfLoanFromRelatedPartyInExchangeOfAsset
0 usd
CY2023 LAMY Proceeds Of Loan From Related Party In Exchange Of Asset
ProceedsOfLoanFromRelatedPartyInExchangeOfAsset
0 usd
CY2024 LAMY Proceeds From Note Payable Against Acquisition Of Intangibles
ProceedsFromNotePayableAgainstAcquisitionOfIntangibles
0 usd
CY2023 LAMY Proceeds From Note Payable Against Acquisition Of Intangibles
ProceedsFromNotePayableAgainstAcquisitionOfIntangibles
0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83165 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zONk8Mj4R3z5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates and Assumptions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2022Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
15100 usd
CY2024 us-gaap Depreciation
Depreciation
5033 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10148 usd
CY2022Q2 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
29000 usd
CY2024Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2024 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9667 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19463 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-17465 usd
CY2024 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
17465 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17465 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17465 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
83165 usd
CY2024 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-006126-index-headers.html Edgar Link pending
0001683168-24-006126-index.html Edgar Link pending
0001683168-24-006126.txt Edgar Link pending
0001683168-24-006126-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_006.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lamy-20240531.xsd Edgar Link pending
lamy_ex2301.htm Edgar Link pending
lamy_ex3100.htm Edgar Link pending
lamy_ex3200.htm Edgar Link pending
lamy_i10k-053124.htm Edgar Link pending
lamy_i10k-053124_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lamy-20240531_cal.xml Edgar Link unprocessable
lamy-20240531_def.xml Edgar Link unprocessable
lamy-20240531_lab.xml Edgar Link unprocessable
lamy-20240531_pre.xml Edgar Link unprocessable